COMMUNIQUÉS West-GlobeNewswire

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
19/09/2024
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization [...]
GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
19/09/2024
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo® (elafibranor) in the U.S. for [...]
GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société
19/09/2024
Trésorerie et équivalents de trésorerie s’éle vant à 61,6 m illio ns d’euros au 30 juin 2024 n’incluant pas le paiement d’étape de 48,7 millions d’euros facturé en juin 2024 (reçu en août 2024) lors de la première vente [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
19/09/2024
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/09/2024
SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
19/09/2024
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the American Heart [...]
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
19/09/2024
Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira [...]
Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
19/09/2024
Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cytokinetics [...]
Rejuveron Life Sciences AG prend le nom de Centenara Labs AG et fait le point sur les dernières données cliniques
19/09/2024
Les actionnaires approuvent le changement de dénomination sociale sous la marque Centenara Labs AG (« Centenara ») Le changement de marque positionne l’entreprise pour des initiatives stratégiques destinées à soutenir [...]
EON Medical & Wellness: Transforming Healthcare for the Hispanic Community Through Cutting-Edge Telehealth
19/09/2024
Revolutionizing Healthcare Access with Culturally Focused, Language-Accessible Care TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- EON Medical + Wellness , a pioneering force in healthcare, is making waves in the [...]
Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function
19/09/2024
Wegovy ® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy ® (semaglutide 2.4 mg) is the first obesity medication to [...]
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
19/09/2024
Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical [...]
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
19/09/2024
GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock [...]
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
19/09/2024
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and productivity NEW YORK [...]
Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award
19/09/2024
ZUG, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, in collaboration with EURETINA [...]
Innovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to Treat mCRC in JAMA Oncology
19/09/2024
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen receptor (CAR) T cell [...]
CARBIOS and SLEEVER® partner up to co-develop and bring to market first Home Compost biodegradable shrinksleeve labels
19/09/2024
Clermont-Ferrand and Morangis (France), Thursday 19 September 2024 (6pm CEST). CARBIOS , (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the [...]
CARBIOS et SLEEVER® nouent un partenariat de co-développement pour la mise sur le marché des premières étiquettes-sleeves biodégradables Home Compost
19/09/2024
Clermont-Ferrand et Morangis (France), le jeudi 19 octobre 2024 (18h00 CEST) : CARBIOS (Euronext Growth Paris : ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer [...]
Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024
19/09/2024
Data underscore the potential to leverage comprehensive epigenomic profiling from a simple blood test to explore central nervous system disease biology BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Precede Biosciences, a [...]

Pages